PL2767285T3 - TABLETKA ZAWIERAJĄCA 7-[4-(4-BENZO[b]TIOFEN-4-YLOPIPERAZYN-1-YLO)BUTOKSY]-1H-CHINOLIN-2-ON LUB JEGO SÓL - Google Patents

TABLETKA ZAWIERAJĄCA 7-[4-(4-BENZO[b]TIOFEN-4-YLOPIPERAZYN-1-YLO)BUTOKSY]-1H-CHINOLIN-2-ON LUB JEGO SÓL

Info

Publication number
PL2767285T3
PL2767285T3 PL12840025T PL12840025T PL2767285T3 PL 2767285 T3 PL2767285 T3 PL 2767285T3 PL 12840025 T PL12840025 T PL 12840025T PL 12840025 T PL12840025 T PL 12840025T PL 2767285 T3 PL2767285 T3 PL 2767285T3
Authority
PL
Poland
Prior art keywords
quinolin
thiophen
piperazin
benzo
butoxy
Prior art date
Application number
PL12840025T
Other languages
English (en)
Other versions
PL2767285T5 (pl
Inventor
Yoshiharu Inoue
Original Assignee
Otsuka Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48081918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2767285(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharmaceutical Co., Ltd. filed Critical Otsuka Pharmaceutical Co., Ltd.
Publication of PL2767285T3 publication Critical patent/PL2767285T3/pl
Publication of PL2767285T5 publication Critical patent/PL2767285T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Supply Of Fluid Materials To The Packaging Location (AREA)
  • Basic Packing Technique (AREA)
PL12840025.6T 2011-10-14 2012-10-12 TABLETKA ZAWIERAJĄCA 7-[4-(4-BENZO[b]TIOFEN-4-YLOPIPERAZYN-1-YLO)BUTOKSY]-1H-CHINOLIN-2-ON LUB JEGO SÓL PL2767285T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011227057 2011-10-14
EP12840025.6A EP2767285B2 (en) 2011-10-14 2012-10-12 TABLET COMPRISING 7-[4-(4-BENZO[b]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF
PCT/JP2012/076415 WO2013054872A1 (ja) 2011-10-14 2012-10-12 7-[4-(4-ベンゾ[b]チオフェン-4-イル-ピペラジン-1-イル)ブトキシ]-1H-キノリン-2-オン又はその塩を含む錠剤

Publications (2)

Publication Number Publication Date
PL2767285T3 true PL2767285T3 (pl) 2020-04-30
PL2767285T5 PL2767285T5 (pl) 2025-06-02

Family

ID=48081918

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12840025.6T PL2767285T5 (pl) 2011-10-14 2012-10-12 TABLETKA ZAWIERAJĄCA 7-[4-(4-BENZO[b]TIOFEN-4-YLOPIPERAZYN-1-YLO)BUTOKSY]-1H-CHINOLIN-2-ON LUB JEGO SÓL

Country Status (34)

Country Link
US (9) US20140234417A1 (pl)
EP (1) EP2767285B2 (pl)
JP (2) JP6084161B2 (pl)
KR (1) KR102072371B1 (pl)
CN (2) CN103889425B (pl)
AP (1) AP2014007564A0 (pl)
AR (1) AR088319A1 (pl)
AU (1) AU2012321723C1 (pl)
BR (1) BR112014008603A2 (pl)
CA (1) CA2851588C (pl)
CL (1) CL2014000909A1 (pl)
CO (1) CO6950480A2 (pl)
CY (1) CY1122460T1 (pl)
DK (1) DK2767285T4 (pl)
EA (1) EA032930B1 (pl)
ES (1) ES2762479T5 (pl)
FI (1) FI2767285T4 (pl)
HR (1) HRP20200037T4 (pl)
HU (1) HUE047493T2 (pl)
IL (1) IL231513B (pl)
IN (1) IN2014DN02055A (pl)
JO (1) JO3753B1 (pl)
LT (1) LT2767285T (pl)
MX (1) MX376092B (pl)
MY (1) MY173370A (pl)
PH (1) PH12014500607A1 (pl)
PL (1) PL2767285T5 (pl)
PT (1) PT2767285T (pl)
SG (2) SG10201608412SA (pl)
SI (1) SI2767285T2 (pl)
TW (1) TWI634908B (pl)
UA (1) UA114411C2 (pl)
WO (1) WO2013054872A1 (pl)
ZA (1) ZA201402333B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
JO3753B1 (ar) * 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
JP5936732B1 (ja) * 2015-03-05 2016-06-22 日本カラコン合同会社 フィルムコーティング組成物
CN105106142B (zh) * 2015-09-22 2018-05-22 成都欣捷高新技术开发有限公司 一种含有依匹哌唑的冻干口服制剂及其制备方法
CN106994119A (zh) * 2016-01-22 2017-08-01 浙江华海药业股份有限公司 含有依匹哌唑或其盐的口腔崩解片及其制备方法
BR112018015369A2 (pt) * 2016-02-19 2018-12-18 Jiangsu Hengrui Medicine Co., Ltd. composição farmacêutica contendo inibidor de jak cinase ou sal farmaceuticamente aceitável do mesmo
CN109414051A (zh) * 2016-06-28 2019-03-01 株式会社日本抗菌总和研究所 赋形剂和片剂
JP7060878B2 (ja) * 2016-07-27 2022-04-27 日本臓器製薬株式会社 メトトレキサート含有フィルムコーティング錠
WO2018033484A1 (en) 2016-08-16 2018-02-22 Hexal Aktiengesellschaft Pharmaceutical compositions of a benzothiophene compound
WO2018033481A1 (en) 2016-08-16 2018-02-22 H E X A L Aktiengesellschaft Immediate release tablet of a benzothiophene compound
CN106496206A (zh) * 2016-08-31 2017-03-15 安徽省润生医药股份有限公司 一种依匹哌唑新的制备方法
US10919898B2 (en) * 2017-02-23 2021-02-16 Boehringer Ingelheim International Gmbh Medical use of compound III
JP7166754B2 (ja) 2017-11-22 2022-11-08 沢井製薬株式会社 ダサチニブ無水物含有製剤
EP3501506B1 (en) 2017-12-19 2019-10-09 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising brexpiprazole
EP3545950A1 (en) * 2018-03-26 2019-10-02 Adamed sp. z o.o. Pharmaceutical composition comprising brexpiprazole
JPWO2021029020A1 (pl) * 2019-08-13 2021-02-18
WO2021095092A1 (ja) * 2019-11-11 2021-05-20 大塚製薬株式会社 口腔内崩壊錠
CN112168794A (zh) * 2020-10-27 2021-01-05 浙江诺得药业有限公司 一种布瑞哌唑片的制备方法
TWI820674B (zh) * 2021-04-13 2023-11-01 大陸商上海雲晟研新生物科技有限公司 布瑞哌唑物口腔薄膜劑、其製備方法及用途
EP4374856A1 (en) 2022-11-23 2024-05-29 Sanovel Ilac Sanayi Ve Ticaret A.S. A process for tablets comprising brexpiprazole

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562375B1 (en) * 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
AU2002353659A1 (en) * 2001-12-18 2003-07-15 Synthon B.V. Simvastatin dosage forms
JP4584706B2 (ja) * 2002-05-03 2010-11-24 イスラエル インスティチュート フォー バイオロジカル リサーチ 中枢及び末梢神経系障害を治療するための方法及び組成物、並びにそれらに有用な新規の化合物
KR100824193B1 (ko) 2003-04-29 2008-04-21 화이자 인코포레이티드 고혈압 치료에 유용한5,7-디아미노피라졸로[4,3-d]피리미딘
RU2358992C2 (ru) * 2003-06-09 2009-06-20 Дау Глобал Текнолоджиз Инк. Стабилизированные органоборановые инициаторы полимеризации и способные к полимеризации композиции
JP2006061067A (ja) * 2004-08-26 2006-03-09 Asahi Kasei Life & Living Corp 酸素インジケーター
GB0504203D0 (en) * 2005-03-01 2005-04-06 Novartis Ag Organic compounds
EP1858514B1 (en) 2005-03-17 2014-11-26 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
JP4315393B2 (ja) * 2005-04-14 2009-08-19 大塚製薬株式会社 複素環化合物
TWI320783B (en) * 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
DK1808164T3 (da) 2006-01-05 2009-04-20 Teva Pharma Vådgranuleringsmetode til fremstilling af farmaceutiske sammensætninger af aripiprazol
JP4806595B2 (ja) * 2006-07-05 2011-11-02 富士フイルム株式会社 固体撮像素子駆動装置及びデジタルカメラ
JP4540700B2 (ja) * 2006-10-13 2010-09-08 大塚製薬株式会社 医薬
WO2008106059A1 (en) * 2007-02-26 2008-09-04 Merck & Co., Inc. Formulations for cathepsin k inhibitors
JP5432720B2 (ja) * 2007-03-13 2014-03-05 武田薬品工業株式会社 2−[[6−[(3r)−3−アミノ−1−ピペリジニル]−3,4−ジヒドロ−3−メチル−2,4−ジオキソ−1(2h)−ピリミジニル]メチル]−4−フルオロベンゾニトリルを含む固形製剤
KR20100016270A (ko) * 2007-05-11 2010-02-12 산텐 세이야꾸 가부시키가이샤 비맥각계의 선택적 d2 수용체 작용제를 유효 성분으로서 함유하는 후안부 질환의 예방 또는 치료제
KR20100099113A (ko) * 2007-10-12 2010-09-10 아스트라제네카 아베 만니톨 및/또는 미세결정질 셀룰로스를 포함하는 지보텐탄 조성물
JP5463564B2 (ja) * 2009-05-22 2014-04-09 国立大学法人信州大学 耐熱性及び耐塩性セルラーゼ製剤
TR201000948A1 (tr) 2010-02-09 2011-08-22 Sanovel İlaç San.Ve Ti̇c.A.Ş. Aripiprazol formülasyonları.
TWI636784B (zh) 2011-04-05 2018-10-01 大塚製藥股份有限公司 含7-〔4-(4-苯並〔b〕噻吩-4-基-哌-1-基)丁氧基〕-1H-喹啉-2-酮之醫藥組成物與套組,以及彼之用途
ES2606511T3 (es) 2011-04-06 2017-03-24 Biovaxim Limited Composiciones farmacéuticas para prevenir y/o tratar una enfermedad por VIH en seres humanos
JO3753B1 (ar) * 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه

Also Published As

Publication number Publication date
JP2017088610A (ja) 2017-05-25
IL231513A0 (en) 2014-04-30
AU2012321723A1 (en) 2014-05-15
EP2767285A4 (en) 2015-03-11
CN103889425A (zh) 2014-06-25
EP2767285A1 (en) 2014-08-20
HRP20200037T1 (hr) 2020-03-20
JP6084161B2 (ja) 2017-02-22
CN103889425B (zh) 2018-08-03
MX2014004135A (es) 2014-07-24
DK2767285T4 (da) 2025-04-22
DK2767285T3 (da) 2020-01-27
US20220331311A1 (en) 2022-10-20
JO3753B1 (ar) 2021-01-31
MX376092B (es) 2025-03-07
US20180008600A1 (en) 2018-01-11
SI2767285T2 (sl) 2025-06-30
ES2762479T3 (es) 2020-05-25
CL2014000909A1 (es) 2014-11-21
BR112014008603A2 (pt) 2017-04-18
CN107397730A (zh) 2017-11-28
EA032930B1 (ru) 2019-08-30
KR20140075754A (ko) 2014-06-19
CY1122460T1 (el) 2021-01-27
HRP20200037T4 (hr) 2025-05-23
US10307419B2 (en) 2019-06-04
LT2767285T (lt) 2020-02-10
AU2012321723B2 (en) 2017-07-20
WO2013054872A1 (ja) 2013-04-18
AR088319A1 (es) 2014-05-28
CA2851588C (en) 2019-07-02
KR102072371B1 (ko) 2020-02-03
IL231513B (en) 2020-01-30
SI2767285T1 (sl) 2020-03-31
EP2767285B2 (en) 2025-02-19
US20260207583A1 (en) 2026-07-23
SG2014013783A (en) 2014-06-27
NZ622639A (en) 2015-11-27
PT2767285T (pt) 2020-01-21
AU2012321723C1 (en) 2017-11-02
TWI634908B (zh) 2018-09-11
JPWO2013054872A1 (ja) 2015-03-30
PH12014500607A1 (en) 2014-04-21
CO6950480A2 (es) 2014-05-20
US20170165258A1 (en) 2017-06-15
FI2767285T4 (fi) 2025-05-08
US20160158227A1 (en) 2016-06-09
CA2851588A1 (en) 2013-04-18
US20240277703A1 (en) 2024-08-22
ES2762479T5 (en) 2025-05-30
PL2767285T5 (pl) 2025-06-02
EP2767285B1 (en) 2019-11-27
EA201490783A1 (ru) 2014-07-30
SG10201608412SA (en) 2016-12-29
US20140234417A1 (en) 2014-08-21
IN2014DN02055A (pl) 2015-05-15
US20190240215A1 (en) 2019-08-08
MY173370A (en) 2020-01-21
US20210023078A1 (en) 2021-01-28
ZA201402333B (en) 2015-07-29
AP2014007564A0 (en) 2014-04-30
TW201318651A (zh) 2013-05-16
UA114411C2 (uk) 2017-06-12
HUE047493T2 (hu) 2020-04-28

Similar Documents

Publication Publication Date Title
SG10201608412SA (en) TABLET COMPRISING 7-[4-(4-BENZO[ b ]THIOPHEN-4-YL-PIPERAZIN-1-YL) BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF
NO2023032I1 (en) Deucravacitinib or a pharmaceutically acceptable salt thereof
LU91773B1 (en) Capacitive sensor including resonant network
EP2742497A4 (en) PROXIMITY LABEL
GB201217531D0 (en) ARMv7-M Asset Protection Proposal
GB201113478D0 (en) Sensing systems
LU91843B1 (en) Plural-frequency capacitive occupancy sensing system
EP2653006A4 (en) Wireless sensor network information swarming
GB201506841D0 (en) A centralisation system
PL2841425T3 (pl) Antybakteryjne pochodne chinoliny
PT2575503E (pt) Produto compreendendo catequinas
GB201108356D0 (en) Event identification
EP2762479A4 (en) OXAZOLIDINONE ANTIBACTERIAL MEDICINE BASED ON BIARYLIC HETEROCYCLE SUBSTITUTED
GB201206384D0 (en) Antibacterial drug derivatives
GB201219102D0 (en) In-memory continuous data protection
PT2841426T (pt) Derivados de quinolina antibacterianos
HUE12715191T1 (hu) Szinterelt üvegtermék
GB2492816B (en) Medicines spoon
AU337630S (en) Cardigan
AU338175S (en) Cardigan
AU338686S (en) Cardigan
GB201108458D0 (en) Card protector
GB201112179D0 (en) Drop alarm
GB201206386D0 (en) Antibacterial drug derivaties
AU332419S (en) Cardigan